"OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females

Supplemental Digital Content is available in the text. Click to show full abstract

Supplemental Digital Content is available in the text.

Keywords: depressive disorder; major depressive; onabotulinumtoxina treatment; phase randomized; disorder phase; treatment major

Journal Title: International Clinical Psychopharmacology
Year Published: 2019

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended